Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial-Reference-Cited by-同舟云学术

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Published:2017-12 Issue:12 Volume:4 Page:e573-e583
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Aguilar-Guisado Manuela,Espigado Ildefonso,Martín-Peña Almudena,Gudiol Carlota,Royo-Cebrecos Cristina,Falantes José,Vázquez-López Lourdes,Montero María Isabel,Rosso-Fernández Clara,de la Luz Martino María,Parody Rocío,González-Campos José,Garzón-López Sebastián,Calderón-Cabrera Cristina,Barba Pere,Rodríguez Nancy,Rovira Montserrat,Montero-Mateos Enrique,Carratalá Jordi,Pérez-Simón José Antonio,Cisneros José Miguel

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

2. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer;Pizzo;Am J Med,1979

3. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial;Sanz;J Antimicrob Chemother,2002

4. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia;Walsh;N Engl J Med,2004

5. The new antibiotic mantra—‘shorter is better’;Spellberg;JAMA Intern Med,2016

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals;Antibiotics;2024-08-30

2. Oncology Intensive Care Units: Distinguishing Features and Clinical Considerations;Journal of Intensive Care Medicine;2024-08-23

3. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study;Scientific Reports;2024-08-06

4. Early stoppage of empirical antibiotic therapy at clinical improvement in paediatric leukaemia patients with high-risk febrile neutropenia (ESAT-HR-FN study): Study protocol of a single centre investigator initiated randomised open label non-inferiority trial;Heliyon;2024-08

5. Antibiotic practice and stewardship in the management of neutropenic fever: a survey of US institutions;Infection Control & Hospital Epidemiology;2024-08-01